Influenza surveillance in Russia based on epidemiological and laboratory data for the period from 2005 to 2012

American Journal of Infectious Diseases

Volumn 9, Issue 3, 2013, Pages 77-93

  Anna, Sominina ^a   Burtseva, Elena ^b   Eropkin, Mikhail ^a   Karpova, Ludmila ^a   Zarubaev, Vladimir ^a   Smorodintseva, Elizaveta ^a   Konovalova, Nadezhda ^a   Danilenko, Daria ^a   Prokopetz, Alexandra ^a   Grudinin, Mikhail ^a   Pisareva, Maria ^a   Anfimov, Pavel ^a   Stolyarov, Kirill ^a   Kiselev, Oleg ^a   Shevchenko, Elena ^b   Ivanova, Valeriya ^b   Trushakova, Svetlana ^b   Breslav, Nataliya ^b   Lvov, Dmitriy ^b   Klimov, Alexander ^c   Moen, Ann ^c   Cox, Nancy ^c   more..

^a Research Institute of Influenza   (Russian Federation)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antigenic properties; Antivirals; Hospitalization; Influenza; Laboratory confirmation; Morbidity; Mortality; Sentinel surveillance; Virus; Virus isolation

Indexed keywords

OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ARTICLE; CARDIOVASCULAR DISEASE; DEATH; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; EPIDEMIC; FREEZE DRYING; GROWTH RATE; HOSPITALIZATION; HUMAN; IMMUNITY; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA B; INFLUENZA VIRUS A H3N2; LETHALITY; LUNG DISEASE; MOLECULAR GENETICS; MORBIDITY; MORTALITY; NEUROMUSCULAR DISEASE; NONHUMAN; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL SURVEILLANCE; VIRUS ISOLATION;

EID: 84886895672     PISSN: 15536203     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajidsp.2013.77.93     Document Type: Article

References (17)

1. Bhatt S., E.C. Holmes and O.G. Pybus, 2011. The genomic rate of molecular adaptation of the human influenza A virus. Mol. Biol. Evol., 28: 2443-2451. DOI: 10.1093/molbev/msr044
2. Eropkin, M.Y., D.M. Danilenko, N.I. Konovalova, A.V. Ivanova and T.M. Gudkova et al., 2011. Pandemic influenza 2009 in Russia: Isolation, antigenic analysis and biological properties of viruses. Influenza Other Respiratory Viruses, 5: 416-418. DOI: 10.1111/j.1750-2659.2011.00225x
3. Guo, L., R.J. Garten, A.S. Foust, W.M. Sessions and M. Ikomo-Adhiambo et al., 2009. Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay. Antiviral Res., 82: 29-33. DOI: 10.1016/j.antiviral.2009.01.004
4. Hancock, K., V. Veguilla, X. Lu, W. Zhong and E.N. Butler et al., 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. New Engl. J. Med., 361: 1945-1952. DOI: 10.1056/NEjMoa0906453
5. Ivanova, A.V., D.M. Danilenko, T.G. Lobova, T.M. Gudkova and V.A. Grigorieva et al., 2011. Antigenic and biological properties of influenza type B viruses isolated in Russia in 2006-2010. Epidemiol. Vaccinoprophilaktika, 1: 4-8.
6. Karpova, L.S., I.G. Marinich, T.P. Stolyarova and N.M. Popovtseva, 2010. Analysis of influenza epidemic A/California/07/2009 (H1N1) in Russia during the season 2009-2010. Epidemiol. Vaccinoprophilaktika, 3: 23-30.
7. Konovalova, N.I., M.Y. Eropkin, T.M. Gudkova, V.A. Grigorieva and D.M. Danilenko et al., 2010. Etiological characteristics of the influenza epidemics 2006-2009 in the Russian Federation. Voprosy Virusol., 55: 9-16. PMID: 20886706
8. Lvov, D.K., E.I. Burtseva, A.G. Prilipov, M.V. Bazarova and L.V. Kolobukhina et al., 2009. The 24 May, 2009 isolation of the first A/IIV-Moscow/01/2009 (H1N1)swl strain similar to swine A(H1N1) influenza virus from the first Moscow case detected on May 21, 2009 and its deposit in the State Collection of Viruses (SCV No.2452 dated May 24, 2009). Voprosy Virusol., 54: 10-14. PMID: 19882896
9. Pica, N., R. Hai, F. Krammer, T.T. Wang and J. Maamary et al., 2012. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. PNAS, 109: 2573-2578. DOI: 10.1073/pnas.1200039109
10. Smee, D.F., B.L. Hurst, M.H. Wong, K.W. Bailey and J.D. Morrey, 2009. Effects of double combinations of amantadine, oseltamivir and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrob. Agents Chemother., 53: 2120-8. DOI: 10.1128/AAC.01012-08
11. Smorodintsev, A.A., 1984. Origin of Pandemic Strains of Influenza a Virus. In: Influenza and its Prophylaxis, Medicine, Leningrad, pp: 113-138.
12. Sominina, A.A., M.P. Grudinin, M.I. Eropkin, L.S. Karpova and M.M. Pisareva et al., 2011. Analysis of pandemic influenza in Russia as part of the global process based on data of the influenza monitoring reference center. J. Microbiol. Epidemiol. Immunobiol., 3: 20-26. PMID21809641
13. Taubenberger, J.K., D. Baltimore, P.C. Doherty, H. Markel and D.M. Morens et al., 2012. Reconstruction of the 1918 influenza virus: Unexpected rewards from the past. mBio, 3: e00201-e00212. DOI: 10.1128/mBio.00201-12
14. CDCP, 2011. Update: Influenza activity---United States, 2010--11 Season and composition of the 2011--12 influenza vaccine. Centers for Disease Control and Prevention.
15. WHO, 2009. WHO Regional Office for Europe Guidance for Sentinel Influenza Surveillance in Humans. WHO/Europe Press, Copenhagen, Denmark, pp: 80.
16. WHO, 2011. Use of neuraminidase inhibition assays to determine the susceptibility of influenza viruses to antiviral drugs. Manual for the laboratory diagnosis and virological surveillance of influenza pp.103-115.
17. Xu, R., D.C. Ekiert, J.C. Krause, R. Hai and J.E. Crowe Jr. et al., 2010. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza Virus. Science, 328: 357-360. DOI: 10.1126/science.1186430